QRxPharma has announced the results of a Phase I trial for MoxDuo CR, a controlled-release Dual-Opioid designed to provide 12 hours of pain relief in patients suffering from moderate to severe chronic ...
SHENZHEN, CHINA, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Gelonghui released a Press Release on "China Medical System Holdings Limited’s innovative product Methylthioninium Chloride Enteric-coated ...
If you’re looking at treatment options for depression, you may want to learn more about Wellbutrin (bupropion). It’s a prescription drug that comes in two forms:* a sustained-release (SR) tablet and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback